Keler Tibor is EXECUTIVE VP & CSO of Celldex Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Celldex Therapeutics, Inc.
20 Jun 23
4
Celldex Therapeutics, Inc.
9 Dec 22
4
Celldex Therapeutics, Inc.
17 Jun 22
4
Celldex Therapeutics, Inc.
21 Jun 21
4
Celldex Therapeutics, Inc.
19 Jun 20
4
Celldex Therapeutics, Inc.
10 Jun 20
4
Celldex Therapeutics, Inc.
20 Jun 19
4
Celldex Therapeutics, Inc.
18 Jun 18
4
Celldex Therapeutics, Inc.
15 Jun 18
4
Celldex Therapeutics, Inc.
16 Jun 17
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | CLDX Celldex Therapeutics | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 36.87 | 92,000 | 3.39 mm | 92,000 |
7 Dec 22 | CLDX Celldex Therapeutics | Common Stock, par value $0.001 per share | Sell | Dispose S | No | No | 36.9283 | 16,860 | 622.61 k | 7,357 |
7 Dec 22 | CLDX Celldex Therapeutics | Common Stock, par value $0.001 per share | Option exercise | Acquire M | No | No | 2.78 | 16,860 | 46.87 k | 24,217 |
7 Dec 22 | CLDX Celldex Therapeutics | Incentive Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.78 | 16,860 | 46.87 k | 43,140 |